EUVIMEDEUVIMED entdecken
Open Access

PLL-g-PEG Polymer Inhibits Antibody-Drug Conjugate Uptake into Human Corneal Epithelial Cells In Vitro

David Kleinman iD, Sana Iqbal iD, Anita K Ghosh, Sean D Ogle, Simon Kaja iD, Mark Mitchnick, Jenni J Hakkarainen iD

Journal of Ocular Pharmacology and Therapeutics · 2024

DOI: 10.1089/jop.2024.0019 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Journal of Ocular Pharmacology and Therapeutics, 2024. Verfasst von David Kleinman und 6 weiteren Autor:innen. Beteiligte Einrichtung: Calm Water Therapeutics LLC, Rochester, New York, USA. Hauptthemen laut MEDLINE: Immunoconjugates, Polyethylene Glycols, Epithelium, Corneal. Die Arbeit wurde bisher 8-mal zitiert (Crossref) und nennt 38 Literaturangaben. Der Volltext ist frei in PubMed Central verfügbar. Gefördert von: NEI NIH HHS.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Purpose

Antibody-drug conjugates (ADCs) are a relatively recent advance in the delivery of chemotherapeutics that improve targeting of cytotoxic agents. However, despite their antitumor activity, severe ocular adverse effects, including vision loss, have been reported for several ADCs. The nonspecific uptake of ADCs into human corneal epithelial cells (HCECs) and their precursors via macropinocytosis has been proposed to be the primary mechanism of ocular toxicity. In this study, we evaluated the ability of a novel polymer, poly(l-lysine)-graft-poly(ethylene glycol) (PLL-g-PEG), to decrease the ADC rituximab-mc monomethylauristatin F (MMAF) (RIX) uptake into human corneal epithelial (HCE-T) cells.

Methods

HCE-T cells were exposed to increasing concentrations of RIX to determine inhibition of cell proliferation. HCE-T cells were treated with PLL-g-PEG, the macropinocytosis inhibitor 5-(N-ethyl-N-isopropyl) amiloride (EIPA), or vehicle. After 30 min of incubation, RIX was added. ADC was detected by fluorescent anti-human immunoglobulin G and fluorescently conjugated dextran as viewed by microscopy.

Results

RIX caused dose-dependent inhibition of HCE-T cell proliferation. EIPA significantly reduced RIX uptake and decreased macropinocytosis as assessed by direct quantification of RIX using a fluorescently conjugated anti-human antibody as well as quantification of macropinocytosis using fluorescently conjugated dextran. PLL-g-PEG resulted in a dose-dependent inhibition of RIX uptake with half-maximal inhibitory concentrations of 0.022%-0.023% PLL-g-PEG.

Conclusion

The data show PLL-g-PEG to be a potent inhibitor of RIX uptake by corneal epithelial cells and support its use as a novel therapeutic approach for the prevention of ocular adverse events associated with ADC therapy.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

ImmunoconjugatesPolyethylene GlycolsEpithelium, CornealHumansPolylysineCell ProliferationEpithelial CellsOligopeptidesAmiloridePolymersCells, CulturedPinocytosis

Stichwörter der Autor:innen

antibody-drug conjugatecorneamacropinocytosisocular surface disease

Substanzen

ImmunoconjugatesPolyethylene GlycolsPolylysineOligopeptidesmonomethylauristatin FAmiloridePolymersethylisopropylamiloride

Autor:innen und Institutionen

  • Calm Water Therapeutics LLC, Rochester, New York, USA.
  • Graduate Program in Molecular Pharmacology and Therapeutics, Health Sciences Division, Loyola University Chicago, Maywood, Illinois, USA.
  • Department of Molecular Pharmacology & Neuroscience, Stritch School of Medicine, Loyola University Chicago, Maywood, Illinois, USA.
  • Department of Ophthalmology, Stritch School of Medicine, Loyola University Chicago, Maywood, Illinois, USA.
  • Graduate Program in Biochemistry and Molecular Biology, Health Sciences Division, Loyola University Chicago, Maywood, Illinois, USA.
  • Research & Development Division, Experimentica Ltd, Forest Park, Illinois, USA.

ORCID-Profile: David Kleinman, Sana Iqbal, Simon Kaja, Jenni J Hakkarainen

Förderung

  • NEI NIH HHS

Zitieren

APA

Kleinman, D., Iqbal, S., Ghosh, A. K., Ogle, S. D., Kaja, S., Mitchnick, M., & Hakkarainen, J. J. (2024). PLL-g-PEG Polymer Inhibits Antibody-Drug Conjugate Uptake into Human Corneal Epithelial Cells In Vitro. Journal of Ocular Pharmacology and Therapeutics. https://doi.org/10.1089/jop.2024.0019

Vancouver

Kleinman D, Iqbal S, Ghosh AK, Ogle SD, Kaja S, Mitchnick M, et al. PLL-g-PEG Polymer Inhibits Antibody-Drug Conjugate Uptake into Human Corneal Epithelial Cells In Vitro. Journal of Ocular Pharmacology and Therapeutics. 2024. doi:10.1089/jop.2024.0019

BibTeX
@article{Kleinman2024,
  author = {Kleinman, David and Iqbal, Sana and Ghosh, Anita K and Ogle, Sean D and Kaja, Simon and Mitchnick, Mark and Hakkarainen, Jenni J},
  title = {PLL-g-PEG Polymer Inhibits Antibody-Drug Conjugate Uptake into Human Corneal Epithelial Cells In Vitro},
  journal = {Journal of Ocular Pharmacology and Therapeutics},
  year = {2024},
  doi = {10.1089/jop.2024.0019}
}
Kostenlos starten →